Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients

Parkinson’s disease (PD) is a progressive neurodegenerative disease, causing loss of motor and nonmotor function. Diagnosis is based on clinical symptoms that do not develop until late in the disease progression, at which point the majority of the patients’ dopaminergic neurons are already destroyed...

Full description

Bibliographic Details

Published in:	Metabolites
Main Authors:	Chen Dong, Chandrashekhar Honrao, Leonardo O. Rodrigues, Josephine Wolf, Keri B. Sheehan, Matthew Surface, Roy N. Alcalay, Elizabeth M. O’Day
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Subjects:	Parkinson’s disease biomarker metabolite leucine machine learning
Online Access:	https://www.mdpi.com/2218-1989/12/2/149